{"id":7770,"date":"2018-10-15T18:01:26","date_gmt":"2018-10-15T22:01:26","guid":{"rendered":"http:\/\/localhost:10028\/uncategorized\/what-you-should-know-about-fourniers-gangrene\/"},"modified":"2022-08-18T21:16:13","modified_gmt":"2022-08-19T01:16:13","slug":"co-powinienes-wiedziec-o-zgorzeli-fourniera","status":"publish","type":"post","link":"https:\/\/napolilaw.lemonadestand.org\/pl\/article\/co-powinienes-wiedziec-o-zgorzeli-fourniera\/","title":{"rendered":"Co powiniene\u015b wiedzie\u0107 o gangrenie Fourniera"},"content":{"rendered":"

Ameryka\u0144ska Agencja ds. \u017bywno\u015bci i Lek\u00f3w (FDA)<\/a> wyda\u0142a ostrze\u017cenie pod koniec sierpnia 2018 r. o zwi\u0105zku mi\u0119dzy lekami na cukrzyc\u0119 a rzadk\u0105, ale zagra\u017caj\u0105c\u0105 \u017cyciu chorob\u0105 zwan\u0105 zgorzel\u0105 Fourniera. Ostrze\u017cenie dotyczy niekt\u00f3rych inhibitor\u00f3w zatwierdzonych przez FDA (SGLT2), o kt\u00f3rych m\u00f3wi si\u0119, \u017ce zapobiega\u0107 nerkom<\/a> z ponownego wch\u0142aniania cukru do krwi, co pomaga obni\u017cy\u0107 poziom cukru we krwi oraz zmniejsza ryzyko zawa\u0142u serca i udaru m\u00f3zgu u os\u00f3b doros\u0142ych z cukrzyc\u0105 cukrzyca typu 2<\/a>. These medications include, but are not limited to, Invokana, Jardiance, and other SGLT2 inhibitors produced and distributed by global pharmaceutical companies. The warning was issued as a result of 12 confirmed cases of Fournier\u2019s gangrene linked to taking SGLT2 inhibitors between March 2013 and May 2018. The FDA\u2019s warning states that while there are only 12 confirmed cases linked to SGLT2 inhibitors, to include seven men and five women, the estimated 1.7 million patients who were prescribed these inhibitors in 2017 may potentially be at risk. The pharmaceutical attorneys at Napoli Shkolnik , along with the FDA, urge any individuals who are or may be experiencing symptoms to seek medical attention immediately. For patients and health professionals who notice side effects from using SGLT2 inhibitors, the FDA requests that you report your symptoms to the Zegarek medyczny FDA<\/a> program do raportowania od razu.<\/p>\n

Today, the pharmaceutical lawyers at Napoli Shkolnik will share useful statistics and facts, and explain the risk factors and symptoms of Fournier\u2019s gangrene. Should you or a loved one fall under the common risk factors or display symptoms, contact a health professional immediately. Then, reach out to Napoli Shkolnik \u2019s dedicated spory farmaceutyczne<\/a> zespo\u0142u, aby om\u00f3wi\u0107 potencjalne roszczenie.<\/p>\n

Zrozumienie gangreny Fourniera<\/h2>\n

The Klinika majonezu<\/a> definiuje gangren\u0119 jako \u201e\u015bmier\u0107 tkanki cia\u0142a spowodowan\u0105 brakiem przep\u0142ywu krwi lub powa\u017cn\u0105 infekcj\u0105 bakteryjn\u0105\u201d, kt\u00f3ra zazwyczaj dotyka ko\u0144czyn. Zgorzel Fourniera to A zaka\u017cenie martwicze<\/a> jest to niezwykle rzadkie, ale cz\u0119sto oszpecaj\u0105ce, a nawet \u015bmiertelne. Ta powa\u017cna infekcja bakteryjna atakuje tkank\u0119 pod sk\u00f3r\u0105 otaczaj\u0105c\u0105 tkanki mi\u0119kkie (mi\u0119\u015bnie, nerwy, naczynia krwiono\u015bne i t\u0142uszcz) narz\u0105d\u00f3w p\u0142ciowych; dok\u0142adniej krocze mi\u0119dzy sromem a moszn\u0105. Podczas gdy gangrena Fourniera zwykle dotyka m\u0119\u017cczyzn, znane s\u0105 przypadki u kobiet i dzieci.<\/p>\n

Przydatne statystyki i fakty<\/h3>\n